Q1 2025 Holdings
Filed 2025-05-15 | 44 holdings | $1.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $310.6M | 3,507,164 | 25.4% |
| Biolife Solutions Inc(BLFS) | COM NEW | 09062W204 | $198.9M | 8,707,165 | 16.3% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $130.8M | 3,697,933 | 10.7% |
| Standard Biotools Inc(LAB) | COM | 34385P108 | $82.2M | 76,075,636 | 6.7% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $60.4M | 2,045,000 | 4.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $57.5M | 900,783 | 4.7% |
| Illumina Inc(ILMN) | COM | 452327109 | $47.2M | 595,000 | 3.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $32.4M | 120,000 | 2.6% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $28.9M | 326,378 | 2.4% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $27.8M | 1,425,562 | 2.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $23.8M | 9,098,574 | 1.9% |
| Codexis Inc(CDXS) | COM | 192005106 | $21.8M | 8,100,000 | 1.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $18.3M | 3,995,571 | 1.5% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $17.5M | 405,000 | 1.4% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $15.2M | 1,295,361 | 1.2% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $14.2M | 2,000,000 | 1.2% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $13.5M | 990,000 | 1.1% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $12.1M | 700,000 | 1.0% |
| Beigene LTD(ONC) | SPONSORED ADS | 07725L102 | $10.9M | 40,000 | 0.9% |
| Guardant Health Inc(GH) | COM | 40131M109 | $10.7M | 250,000 | 0.9% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $10.4M | 946,357 | 0.9% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $9.9M | 2,000,000 | 0.8% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $8.2M | 276,308 | 0.7% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $8.1M | 100,000 | 0.7% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.8M | 635,000 | 0.6% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $7.3M | 250,000 | 0.6% |
| Moderna Inc(MRNA) | COM | 60770K107 | $6.4M | 225,000 | 0.5% |
| Hims & Hers Health Inc(HIMS) | COM CL A | 433000106 | $5.9M | 200,000 | 0.5% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $3.8M | 6,732,971 | 0.3% |
| Verastem Inc(VSTM) | COM NEW | 92337C203 | $3.6M | 600,000 | 0.3% |
| Septerna Inc(SEPN) | COM | 81734D104 | $3.2M | 553,268 | 0.3% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.9M | 775,000 | 0.2% |
| Absci Corporation(ABSI) | COM | 00091E109 | $2.4M | 973,260 | 0.2% |
| Teladoc Health Inc(TDOC) | COM | 87918A105 | $2.4M | 300,000 | 0.2% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $1.5M | 3,212,316 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $1.0M | 100,000 | 0.1% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.0M | 148,333 | 0.1% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $874.6K | 165,323 | 0.1% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $854.0K | 723,767 | 0.1% |
| Prime Medicine Inc(PRME) | COM | 74168J101 | $730.7K | 367,175 | 0.1% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $399.1K | 86,014 | 0.0% |
| Ginkgo Bioworks Holdings Inc(DNA) | CL A NEW | 37611X209 | $208.0K | 36,493 | 0.0% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $171.3K | 125,000 | 0.0% |
| Kronos BIO Inc(KRON1USD) | COM | 50107A104 | $102.2K | 123,839 | 0.0% |